Buys
Open market- Shares
- +1,000
- Avg price
- $17.35
- Total value
- +$17,350
Robert Lorne Hopfner - Director, 10%+ Owner at Evommune, Inc.
Issuer-level insider activity
- Role
- Director, 10%+ Owner
- Issuer ticker
- EVMN on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Robert Lorne Hopfner in Evommune, Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +1,000
- Share %
- 100%
- Total value
- +$17,350
Reported holdings for Robert Lorne Hopfner in Evommune, Inc.
Form 4 holding
Director, 10%+ Owner
Evommune, Inc.
- Security class
- Common Stock
- Shares / value
- 1,632,441
- Estimated value
- $30,608,268
- Report date
- 19 Dec 2025
- Price
- $18.75
- Ownership
- By Pivotal bioVenture Partners Fund I, L.P.
Form 4 holding
Director, 10%+ Owner
Evommune, Inc.
- Security class
- Common Stock
- Shares / value
- 1,441,032
- Estimated value
- $27,019,350
- Report date
- 19 Dec 2025
- Price
- $18.75
- Ownership
- By NFLS Delta III Limited
Form 4 holding
Director, 10%+ Owner
Evommune, Inc.
- Security class
- Common Stock
- Shares / value
- 294,502
- Estimated value
- $5,521,912
- Report date
- 19 Dec 2025
- Price
- $18.75
- Ownership
- By Pivotal bioVenture Partners Fund II, L.P.
Form 4 holding
Director, 10%+ Owner
Evommune, Inc.
- Security class
- Common Stock
- Shares / value
- 4,026
- Estimated value
- $69,851
- Report date
- 19 Dec 2025
- Price
- $17.35
- Ownership
- By Trust
Form 4 holding
Director, 10%+ Owner
Evommune, Inc.
- Security class
- Series A Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 07 Nov 2025
- Price
- Ownership
- By NFLS Delta III Limited
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Evommune, Inc.
- Security class
- Series A Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 07 Nov 2025
- Price
- Ownership
- By Pivotal bioVenture Partners Fund I, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Evommune, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 07 Nov 2025
- Price
- Ownership
- By NFLS Delta III Limited
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Evommune, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 07 Nov 2025
- Price
- Ownership
- By Pivotal bioVenture Partners Fund I, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Evommune, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 07 Nov 2025
- Price
- Ownership
- By NFLS Delta III Limited
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Evommune, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 07 Nov 2025
- Price
- Ownership
- By Pivotal bioVenture Partners Fund II, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Evommune, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 07 Nov 2025
- Price
- Ownership
- By Pivotal bioVenture Partners Fund I, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Evommune, Inc.
- Security class
- Series Seed Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 07 Nov 2025
- Price
- Ownership
- By NFLS Delta III Limited
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Evommune, Inc.
- Security class
- Series Seed Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 07 Nov 2025
- Price
- Ownership
- By Pivotal bioVenture Partners Fund I, L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Evommune, Inc.
- Security class
- Series Seed Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 07 Nov 2025
- Price
- Ownership
- By Trust
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Robert Lorne Hopfner in Evommune, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.